Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment

Bernardino Clavo; Minerva Navarro; Mario Federico; Emma Borrelli; Ignacio J Jorge; Ivone Ribeiro; Juan I Rodríguez-Melcon; Miguel A Caramés; Norberto Santana-Rodríguez; Francisco Rodríguez-Esparragón

doi:10.1093/pm/pnaa459

Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment

Pain Med. 2021 Sep 8;22(9):2138-2141. doi: 10.1093/pm/pnaa459.

Authors

Affiliations

¹ Research Unit.
² Chronic Pain Unit.
³ Radiation Oncology, Dr. Negrín University Hospital, Las Palmas, Spain.
⁴ Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), BioPharm Group, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain.
⁵ Grupo de Investigación Clínica en Oncología Radioterápica (GICOR), Madrid, Spain.
⁶ Department of Medical Biotechnologies, University of Siena, Siena, Italy.
⁷ Section of Thoracic Surgery, Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
⁸ College of Medicine, Department of Surgery, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.

No abstract available

Keywords: Cancer Pain; Cancer Survivorship; Chemotherapy-Induced Side Effects; Chronic Pelvic Pain; Neuropathic Pain; Ozone Therapy; Radiation-Induced Toxicity.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Chronic Pain* / drug therapy
Chronic Pain* / etiology
Combined Modality Therapy
Humans
Neoplasms*
Ozone* / therapeutic use
Pelvic Pain / drug therapy
Pelvic Pain / etiology

Substances

Ozone

Associated data

ClinicalTrials.gov/NCT04299893
EudraCT/2019-000821-37